N8 Medical is a development-stage medical device company focused upon commercializing antimicrobial medical devices and coatings to address the multibillion dollar public health and economic burden associated with medical device-related hospital acquired infections and healthcare-associated infections (HAIs). N8 Medical’s business is based upon the application of a novel, proprietary class of compounds known as ceragenins or CSAs to medical devices. N8 Medical’s premium CERASHIELD™ brand coatings transform ordinary medical devices into high value medical devices with antimicrobial, anti-inflammatory and other therapeutic properties that improve patient outcomes and lower the overall cost of care.
Based on extensive testing and over 45 peer reviewed journal articles, N8 Medical believes that ceragenins offer unparalleled efficacy and cost advantages to prevent HAIs. The use of ceragenins as a platform technology under its CERASHIELD™ brand across numerous device segments with multiple coating options is anticipated to provide N8 Medical with a unique, sustainable competitive advantage over other medical device companies. N8 Medical’s strategy is developing several of its own products while also pursuing strategic partnerships with leading medical device companies.